Microbial Diversity and Composition in Six Different Gastrointestinal Sites among Participants Undergoing Upper Gastrointestinal Endoscopy in Henan, China/Experiment 14

From BugSigDB


Needs review

Curated date: 2024/03/15

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Body of stomach Corpus gastricum,Corpus gastricum (ventriculare),Corpus ventriculare,Corpus ventriculi,Gastric body,Gastric corpus,Stomach body,Body of stomach,body of stomach
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Upper digestive tract disease disease of upper digestive tract,disease or disorder of upper digestive tract,disorder of upper digestive tract,disorder of upper gastrointestinal tract,upper digestive tract disease or disorder,upper gastrointestinal tract disease,Upper digestive tract disease,upper digestive tract disease
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Fecal samples
Group 1 name Corresponds to the case (exposed) group for case-control studies
Non-cardia biopsy samples
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Non-cardia biopsy samples from 40 participants undergoing upper gastrointestinal endoscopy.
Group 0 sample size Number of subjects in the control (unexposed) group
40
Group 1 sample size Number of subjects in the case (exposed) group
40
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
One month before sample collection.

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
Yes
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Richness Number of species
unchanged

Signature 1

Needs review

Curated date: 2024/03/15

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 2B

Description: LEfSe results for characteristic genera in different GI sites.

Abundance in Group 1: increased abundance in Non-cardia biopsy samples

NCBI Quality ControlLinks
Helicobacter

Revision editor(s): Aleru Divine

Signature 2

Needs review

Curated date: 2024/03/15

Curator: Aleru Divine

Revision editor(s): Aleru Divine

Source: Figure 2B

Description: LEfSe results for characteristic genera in different GI sites.

Abundance in Group 1: decreased abundance in Non-cardia biopsy samples

NCBI Quality ControlLinks
Faecalibacterium
Roseburia
Blautia

Revision editor(s): Aleru Divine